TWA
TCI Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38
| Closed | -$7.61K | – | 284 |
|
|
2023
Q1 | $7.61K | Buy |
38
+9
| +31% | +$1.8K | ﹤0.01% | 1247 |
|
|
2022
Q4 | $6.89K | Buy |
29
+25
| +625% | +$5.94K | ﹤0.01% | 1321 |
|
|
2022
Q3 | $1K | Buy |
4
+1
| +33% | +$250 | ﹤0.01% | 2022 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 2256 |
|
|
2022
Q1 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 2207 |
|
|
2021
Q4 | $1K | Sell |
4
-35
| -90% | -$8.75K | ﹤0.01% | 2150 |
|
|
2021
Q3 | $7K | Buy |
39
+36
| +1,200% | +$6.46K | ﹤0.01% | 1312 |
|
|
2021
Q2 | $1K | Sell |
3
-21
| -88% | -$7K | ﹤0.01% | 2152 |
|
|
2021
Q1 | $3K | Buy |
24
+19
| +380% | +$2.38K | ﹤0.01% | 1460 |
|
|
2020
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 1297 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 1232 |
|
|
2020
Q2 | $1K | Sell |
5
-10
| -67% | -$2K | ﹤0.01% | 1180 |
|
|
2020
Q1 | $2K | Buy |
15
+5
| +50% | +$667 | ﹤0.01% | 958 |
|
|
2019
Q4 | $1K | Sell |
10
-1
| -9% | -$100 | ﹤0.01% | 1267 |
|
|
2019
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1207 |
|
|
2019
Q2 | $1K | Sell |
11
-8
| -42% | -$727 | ﹤0.01% | 1124 |
|
|
2019
Q1 | $2K | Buy |
19
+8
| +73% | +$842 | ﹤0.01% | 982 |
|
|
2018
Q4 | $1K | Sell |
11
-7
| -39% | -$636 | ﹤0.01% | 1121 |
|
|
2018
Q3 | $2K | Buy |
18
+7
| +64% | +$778 | ﹤0.01% | 980 |
|
|
2018
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 1228 |
|
|
2018
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 1072 |
|
|
2017
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 1126 |
|
|
2017
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1052 |
|
|
2017
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 1081 |
|
|
2017
Q1 | – | Sell |
-9
| Closed | – | – | 1279 |
|
|
2016
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 1346 |
|
|
2016
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1066 |
|